Search results

Search:
in the keywords: Enteric-coated pellets

Sort By:

Limit search:

Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin

100%

Ostrowski M., Wilkowska E., Bączek T.

Open Medicine

2010

vol. 5

issue 1

83-90

The behavior of dispersible tablets containing enteric-coated pellets and oral suspension, both containing roxithromycin, was investigated using dissolution tests in different media. The dissolution test was performed under different pH conditions. For both dosage forms investigated, the test was conducted at pH 1.2, 4.5, and 6.8. Additionally, for dispersible tablets, the test involving increasing pH was performed at pH 1.2 (acid stage) and afterwards at pH 6.8 (buffer stage). The extent of dissolution was measured using high-performance liquid chromatography (HPLC). In all cases tested, roxithromycin underwent rapid degradation at pH 1.2. Dispersible tablets displayed the features of modified release preparations with a non-complete dissolution during the test times in all media. Conversely, the oral suspension behaved as an immediate release preparation, with degradation at pH 1.2. However, the dissolution of the oral suspension at pH 4.5 and 6.8 was rapid and complete. The role of enteric-coated pellets is to mask the bitter taste of the active substance upon administration. However, the coating showed lack of resistance to media at pH 1.2. Therefore, dispersible tablets containing enteric-coated pellets are not pharmaceutically equivalent to the immediate-release oral suspension.

Refine search results

1 Open Medicine

1 2010

1 Bączek T.

1 Ostrowski M.

1 Wilkowska E.

Search results

Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin